1. Potential therapeutic targets of the JAK2/STAT3 signaling pathway in triple-negative breast cancer
   Lin Long et al, 2024, Frontiers in Oncology CrossRef
2. The Crosstalk between Cancer Stem Cells and Microenvironment Is Critical for Solid Tumor Progression: The Significant Contribution of Extracellular Vesicles
   Chiara Ciardiello et al, 2018, Stem Cells International CrossRef
3. Reporter gene systems for the identification and characterization of cancer stem cells
   Nohemí Salinas-Jazmín et al, 2021, World Journal of Stem Cells CrossRef
4. Targeted Inhibition of miR-221/222 Promotes Cell Sensitivity to Cisplatin in Triple-Negative Breast Cancer MDA-MB-231 Cells
   Shujun Li et al, 2020, Frontiers in Genetics CrossRef
5. The Interleukin-6/Signal Transducer and Activator of Transcription-3/Cystathionine γ-Lyase Axis Deciphers the Transformation Between the Sensitive and Resistant Phenotypes of Breast Cancer Cells
   Zhaoyi Tan et al, 2021, Drug Metabolism and Disposition CrossRef
6. Triple-Negative Breast Cancer: the Current Aspects of Pathogenesis and Therapies
   Shinjit Mani et al, 2022, BioNanoScience CrossRef
7. KDM1A inhibition is effective in reducing stemness and treating triple negative breast cancer
   Mei Zhou et al, 2021, Breast Cancer Research and Treatment CrossRef
8. Non-coding RNAs Related to Cardiometabolic Diseases and Associated to Cancer
   Paul Holvoet, 2021, Non-coding RNAs at the Cross-Road of Cardiometabolic Diseases and Cancer CrossRef
9. STAT signaling as a target for intervention: from cancer inflammation and angiogenesis to non-coding RNAs modulation
   Hardeep Singh Tuli et al, 2022, Molecular Biology Reports CrossRef
10. Folic Acid-Functionalized Nanomedicine: Folic Acid Conjugated Copolymer and Folate Receptor Interactions Disrupt Receptor Functionality Resulting in Dual Therapeutic Anti-Cancer Potential in Breast and Prostate Cancer
    Alexandria DeCarlo et al, 2021, Bioconjugate Chemistry CrossRef
11. The AXL-PYK2-PKCα axis as a nexus of stemness circuits in TNBC
    Lohit Khera et al, 2021, Life Science Alliance CrossRef
12. Inflammation-Driven Breast Tumor Cell Plasticity: Stemness/EMT, Therapy Resistance and Dormancy
    Tamir Baram et al, 2021, Frontiers in Oncology CrossRef
13. Exploring doxorubicin transport in 2D and 3D models of MDA-MB-231 sublines: impact of hypoxia and cellular heterogeneity on doxorubicin accumulation in cells
    Indrė Januškevičienė, 2024, American Journal of Cancer Research CrossRef
14. A Systematic Review to Clarify the Prognostic Values of CD44 and CD44+CD24- Phenotype in Triple-Negative Breast Cancer Patients: Lessons Learned and The Road Ahead
    Mahdi Abdoli Shadbad et al, 2021, Frontiers in Oncology CrossRef
15. Continuous exposure to doxorubicin induces stem cell-like characteristics and plasticity in MDA-MB-231 breast cancer cells identified with the SORE6 reporter
    Nohemí Salinas-Jazmín et al, 2024, Cancer Chemotherapy and Pharmacology CrossRef
16. Effects of Thyroid Hormones on Cellular Development in Human Ovarian Granulosa Tumor Cells (KGN)
    Yakun Yu et al, 2024, Reproductive Sciences CrossRef
17. Pan-cancer analysis of STAT3 indicates its potential prognostic value and correlation with immune cell infiltration in prostate cancer
    Zhouting Tuo et al, 2024, Discover Oncology CrossRef
18. Estrogen Receptor α Mediates Doxorubicin Sensitivity in Breast Cancer Cells by Regulating E-Cadherin
    Xiaoqing Wan et al, 2021, Frontiers in Cell and Developmental Biology CrossRef